Follow
Padmanabh Chivukula
Padmanabh Chivukula
Arcturus Therapeutics
No verified email
Title
Cited by
Cited by
Year
Systemic delivery of factor IX messenger RNA for protein replacement therapy
S Ramaswamy, N Tonnu, K Tachikawa, P Limphong, JB Vega, ...
Proceedings of the National Academy of Sciences 114 (10), E1941-E1950, 2017
2742017
Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel
C Liu, G Zhao, J Liu, N Ma, P Chivukula, L Perelman, K Okada, Z Chen, ...
Journal of controlled release 140 (3), 277-283, 2009
1462009
Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes
Y Bao, Y Jin, P Chivukula, J Zhang, Y Liu, J Liu, JP Clamme, RI Mahato, ...
Pharmaceutical research 30, 342-351, 2013
1092013
Synthesis and characterization of novel aromatic azo bond-containing pH-sensitive and hydrolytically cleavable IPN hydrogels
P Chivukula, K Dušek, D Wang, M Dušková-Smrčková, P Kopečková, ...
Biomaterials 27 (7), 1140-1151, 2006
762006
Lipid nanoparticle-mediated siRNA transfer against PCTAIRE1/PCTK1/Cdk16 inhibits in vivo cancer growth
T Yanagi, K Tachikawa, R Wilkie-Grantham, A Hishiki, K Nagai, ...
Molecular Therapy-Nucleic Acids 5, 2016
542016
Effect of molecular weight of PGG–paclitaxel conjugates on in vitro and in vivo efficacy
D Yang, X Liu, X Jiang, Y Liu, W Ying, H Wang, H Bai, WD Taylor, Y Wang, ...
Journal of controlled release 161 (1), 124-131, 2012
472012
Immune modulatory nanoparticle therapeutics for intracerebral glioma
NK Yaghi, J Wei, Y Hashimoto, LY Kong, K Gabrusiewicz, EK Nduom, ...
Neuro-oncology 19 (3), 372-382, 2017
442017
Allele selective gene editing and uses thereof
P Chivukula, R Wilkie-Grantham, K Tachikawa
US Patent 10,369,232, 2019
422019
Long non-coding RNA BGas regulates the cystic fibrosis transmembrane conductance regulator
SM Saayman, A Ackley, J Burdach, M Clemson, DC Gruenert, ...
Molecular Therapy 24 (8), 1351-1357, 2016
372016
Asymmetric ionizable cationic lipid for RNA delivery
JE Payne, P Chivukula, D Webb
US Patent 9,365,610, 2016
34*2016
Ionizable cationic lipid for RNA delivery
JE Payne, P Chivukula
US Patent 9,593,077, 2017
322017
Development of an mRNA replacement therapy for phenylketonuria
CG Perez-Garcia, R Diaz-Trelles, JB Vega, Y Bao, M Sablad, P Limphong, ...
Molecular Therapy-Nucleic Acids 28, 87-98, 2022
302022
CD8+ T cells mediate protection against Zika virus induced by an NS3-based vaccine
A Elong Ngono, T Syed, AV Nguyen, JA Regla-Nava, M Susantono, ...
Science Advances 6 (45), eabb2154, 2020
262020
Ionizable cationic lipid for RNA delivery
JE Payne, P Chivukula, P Karmali, SP Tanis
US Patent 10,526,284, 2020
222020
Anti-HFRS human IgG produced in transchromosomic bovines has potent hantavirus neutralizing activity and is protective in animal models
CC Perley, RL Brocato, H Wu, C Bausch, E Sullivan, JW Hooper
Frontiers in Microbiology 11, 529650, 2020
212020
Property-driven design and development of lipids for efficient delivery of siRNA
K Rajappan, SP Tanis, R Mukthavaram, S Roberts, M Nguyen, ...
Journal of Medicinal Chemistry 63 (21), 12992-13012, 2020
192020
Coronavirus vaccine compositions and methods
SM Sullivan, D Matsuda, K Tachikawa, P Chivukula, PP Karmali, JH Davis, ...
US Patent 11,744,887, 2023
182023
Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS
T Hirunagi, K Sahashi, K Tachikawa, AI Leu, M Nguyen, R Mukthavaram, ...
Molecular Therapy-Nucleic Acids 24, 1-10, 2021
182021
Trinucleotide MRNA cap analogs
P Chivukula, SP Tanis, JE Payne
US Patent 10,487,105, 2019
152019
Compositions and methods for inducing immune responses
SM Sullivan, D Matsuda, K Tachikawa, P Chivukula, PP Karmali, JH Davis, ...
US Patent 11,759,515, 2023
142023
The system can't perform the operation now. Try again later.
Articles 1–20